Φορτώνει......
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
Immunocompromised patients, including HSCT recipients, may have a poor prognosis after contracting COVID-19 due to the absence of a pathogen-specific adaptive immune response. One of the possible options for severe COVID-19 treatment may be the transfusion of hyperimmune SARS-CoV-2 convalescent plas...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Transfus Apher Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier Ltd.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604030/ https://ncbi.nlm.nih.gov/pubmed/33153902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102983 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|